Eversept Partners, LP - Q4 2022 holdings

$1.14 Billion is the total value of Eversept Partners, LP's 68 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 51.4% .

 Value Shares↓ Weighting
BuyGSK PLCsponsored adr$123,825,940
+41.9%
3,490,457
+18.8%
10.84%
+43.4%
HZNP SellHORIZON THERAPEUTICS PUB L$121,133,955
+54.2%
1,064,446
-16.2%
10.61%
+55.8%
NTRA BuyNATERA INC$107,894,973
+72.7%
2,685,959
+88.4%
9.45%
+74.5%
SNY BuySANOFIsponsored adr$77,650,144
+105.0%
1,603,348
+61.0%
6.80%
+107.2%
 GSK PLCcall$73,572,618
+19.4%
2,093,7000.0%6.44%
+20.6%
UTHR SellUNITED THERAPEUTICS CORP DEL$64,735,737
+21.1%
232,787
-8.8%
5.67%
+22.4%
DHR BuyDANAHER CORPORATION$43,189,420
+2.8%
162,571
+0.0%
3.78%
+3.8%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDsponsored ads$42,978,885
+31.1%
4,712,597
+16.0%
3.76%
+32.4%
SNDX BuySYNDAX PHARMACEUTICALS INC$41,247,146
+41.7%
1,620,713
+33.8%
3.61%
+43.2%
BIIB BuyBIOGEN INC$38,034,408
+136.8%
137,348
+128.4%
3.33%
+139.3%
CTLT NewCATALENT INC$31,132,382691,677
+100.0%
2.73%
ILMN BuyILLUMINA INC$28,321,547
+38.7%
140,067
+30.9%
2.48%
+40.2%
CLDX SellCELLDEX THERAPEUTICS INC NEW$24,904,557
+41.4%
558,774
-10.8%
2.18%
+42.9%
NVST BuyENVISTA HOLDINGS CORPORATION$21,629,776
+4.1%
642,405
+1.5%
1.89%
+5.2%
XBI BuySPDR SER TRs&p biotech$17,935,221
+126.1%
216,087
+116.1%
1.57%
+128.7%
CNC BuyCENTENE CORP DEL$17,596,148
+18.2%
214,561
+12.2%
1.54%
+19.5%
NewHALEON PLCspon ads$15,051,7601,881,470
+100.0%
1.32%
NewELEVANCE HEALTH INC$14,384,70528,042
+100.0%
1.26%
ICLR BuyICON PLC$12,955,115
+590.3%
66,693
+553.1%
1.13%
+595.7%
AVTR BuyAVANTOR INC$12,658,218
+767.4%
600,200
+706.2%
1.11%
+779.4%
THC NewTENET HEALTHCARE CORP$12,421,251254,586
+100.0%
1.09%
MCRB BuySERES THERAPEUTICS INC$12,325,594
-0.8%
2,200,999
+13.7%
1.08%
+0.2%
XENE BuyXENON PHARMACEUTICALS INC$10,871,009
+16.0%
275,704
+6.2%
0.95%
+17.2%
HUM SellHUMANA INC$10,726,489
-10.2%
20,911
-14.9%
0.94%
-9.3%
BCRX NewBIOCRYST PHARMACEUTICALS INC$10,107,991880,487
+100.0%
0.88%
RGEN BuyREPLIGEN CORP$9,651,347
+1316.7%
57,004
+1465.6%
0.84%
+1332.2%
IONS BuyIONIS PHARMACEUTICALS INC$9,101,626
+2.0%
240,975
+19.4%
0.80%
+3.0%
MODN NewMODEL N INC$8,837,213217,880
+100.0%
0.77%
CYH SellCOMMUNITY HEALTH SYS INC NEW$8,648,614
-54.5%
2,001,994
-77.4%
0.76%
-54.1%
PCVX NewVAXCYTE INC$8,556,821178,453
+100.0%
0.75%
LQDA SellLIQUIDIA CORPORATION$8,223,116
+7.9%
1,290,913
-7.9%
0.72%
+8.9%
APLS NewAPELLIS PHARMACEUTICALS INC$8,004,501154,796
+100.0%
0.70%
VERA BuyVERA THERAPEUTICS INCcl a$7,958,810
+139.2%
411,308
+163.4%
0.70%
+142.0%
ISEE NewIVERIC BIO INC$7,509,493350,747
+100.0%
0.66%
XBI  SPDR SER TRcall$7,470,000
+4.6%
90,0000.0%0.65%
+5.7%
TARO BuyTARO PHARMACEUTICAL INDS LTD$6,547,416
-2.2%
225,462
+0.9%
0.57%
-1.2%
PBYI BuyPUMA BIOTECHNOLOGY INC$6,377,414
+78.7%
1,507,663
+0.1%
0.56%
+80.6%
MRK  MERCK & CO INCcall$5,403,265
+28.8%
48,7000.0%0.47%
+29.9%
EOLS NewEVOLUS INC$5,360,443713,774
+100.0%
0.47%
INCY NewINCYTE CORP$5,140,15963,996
+100.0%
0.45%
NewAMARIN CORP PLCspons adr new$3,973,7783,284,114
+100.0%
0.35%
GH SellGUARDANT HEALTH INC$3,974,709
-56.9%
146,129
-14.8%
0.35%
-56.5%
MRUS SellMERUS N V$2,855,081
-48.5%
184,556
-33.3%
0.25%
-47.9%
AVTE NewAEROVATE THERAPEUTICS INC$2,673,68491,252
+100.0%
0.23%
PLRX SellPLIANT THERAPEUTICS INC$2,656,387
-56.8%
137,423
-53.3%
0.23%
-56.2%
CABA SellCABALETTA BIO INC$2,616,585
+618.1%
282,874
-49.5%
0.23%
+615.6%
NewBIOHAVEN LTD$2,576,059185,595
+100.0%
0.23%
TEVA  TEVA PHARMACEUTICAL INDS LTDcall$2,488,848
+13.0%
272,9000.0%0.22%
+14.1%
IQV BuyIQVIA HLDGS INC$2,231,047
+48.4%
10,889
+31.2%
0.20%
+50.0%
A SellAGILENT TECHNOLOGIES INC$1,780,215
-31.9%
11,878
-44.8%
0.16%
-31.3%
AMRX SellAMNEAL PHARMACEUTICALS INC$1,653,610
-82.5%
830,960
-82.3%
0.14%
-82.3%
XOMA SellXOMA CORP DEL$1,598,463
+1.0%
86,873
-1.7%
0.14%
+2.2%
PKI BuyPERKINELMER INC$1,567,379
+19.2%
11,178
+2.3%
0.14%
+20.2%
TECH NewBIO-TECHNE CORP$1,378,70916,635
+100.0%
0.12%
CYH  COMMUNITY HEALTH SYS INC NEWcall$1,351,728
+100.9%
312,9000.0%0.12%
+103.4%
 AADI BIOSCIENCE INC$1,307,608
-9.2%
101,9180.0%0.12%
-8.0%
ARGX SellARGENX SEsponsored adr$1,316,813
+6.5%
3,476
-0.7%
0.12%
+7.5%
HSKA BuyHESKA CORP$1,210,566
+139.1%
19,475
+180.5%
0.11%
+140.9%
NewGOHEALTH INCcl a new$527,95550,522
+100.0%
0.05%
FATE SellFATE THERAPEUTICS INC$439,541
-86.1%
43,562
-69.2%
0.04%
-86.2%
AFMD SellAFFIMED N V$409,478
-89.5%
330,224
-82.5%
0.04%
-89.3%
GOSS SellGOSSAMER BIO INC$334,640
-94.9%
154,212
-71.9%
0.03%
-94.9%
GLYC  GLYCOMIMETICS INC$304,754
+449.2%
100,5790.0%0.03%
+440.0%
ACIU  AC IMMUNE SA$254,162
-35.4%
124,5890.0%0.02%
-35.3%
ELDN  ELEDON PHARMACEUTICALS INC$154,454
-17.4%
67,7430.0%0.01%
-12.5%
CSU  SONIDA SENIOR LIVING INC$147,388
-23.0%
11,7910.0%0.01%
-23.5%
CTLT NewCATALENT INCcall$90,0202,000
+100.0%
0.01%
BOLT  BOLT BIOTHERAPEUTICS INC$40,524
-12.2%
31,1720.0%0.00%0.0%
ExitTHIRD HARMONIC BIO INCco$0-10,000
-100.0%
-0.02%
MRVI ExitMARAVAI LIFESCIENCES HLDGS Icall$0-24,000
-100.0%
-0.05%
MIST ExitMILESTONE PHARMACEUTICALS IN$0-126,826
-100.0%
-0.10%
LH ExitLABORATORY CORP AMER HLDGS$0-7,233
-100.0%
-0.13%
ISRG ExitINTUITIVE SURGICAL INC$0-9,125
-100.0%
-0.15%
AMN ExitAMN HEALTHCARE SVCS INCput$0-19,000
-100.0%
-0.17%
MASS Exit908 DEVICES INC$0-130,768
-100.0%
-0.19%
PNT ExitPOINT BIOPHARMA GLOBAL INC$0-410,052
-100.0%
-0.28%
AERI ExitAERIE PHARMACEUTICALS INC$0-256,289
-100.0%
-0.34%
MRVI ExitMARAVAI LIFESCIENCES HLDGS I$0-160,000
-100.0%
-0.35%
VRDN ExitVIRIDIAN THERAPEUTICS INC$0-478,387
-100.0%
-0.85%
BIIB ExitBIOGEN INCcall$0-37,100
-100.0%
-0.86%
ABMD ExitABIOMED INC$0-52,970
-100.0%
-1.13%
AMRN ExitAMARIN CORP PLCspons adr new$0-11,962,744
-100.0%
-1.13%
BIIB ExitBIOGEN INCput$0-50,000
-100.0%
-1.16%
LNTH ExitLANTHEUS HLDGS INC$0-206,893
-100.0%
-1.26%
ANTM ExitELEVANCE HEALTH INC$0-33,040
-100.0%
-1.30%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-637,139
-100.0%
-8.35%
QQQ ExitINVESCO QQQ TRput$0-781,700
-100.0%
-18.11%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2023-11-08
  • View 13F-HR/A filed 2023-11-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMARIN CORP PLC21Q3 202312.5%
DANAHER CORPORATION21Q3 20238.1%
AFFIMED N V20Q3 20230.9%
ARGENX SE19Q3 20232.0%
GSK PLC18Q2 202213.1%
ASCENDIS PHARMA A/S18Q1 20227.7%
SANOFI18Q4 20227.2%
ENSIGN GROUP INC18Q1 20228.6%
CENTENE CORP DEL18Q3 20231.5%
ZOGENIX INC17Q4 202112.4%

View Eversept Partners, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Eversept Partners, LP Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cabaletta Bio, Inc.February 14, 2023282,8741.0%
Teligent, Inc.Sold outFebruary 16, 202100.0%
Teligent, Inc.February 14, 20204,501,7998.4%

View Eversept Partners, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08

View Eversept Partners, LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Eversept Partners, LP's holdings